Eosinophilic disorders

Journal of Allergy and Clinical Immunology

Volumn 119, Issue 6, 2007, Pages 1291-1300

  Simon, Dagmar ^a   Simon, Hans Uwe ^b  

^a Inselspital   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Allergy; classification; eosinophilia; eosinophilic disorders; eosinophils; hypereosinophilic syndrome; IL 5; infection; leukemia; lymphoma; tumors

Indexed keywords

ABACAVIR; ALLOPURINOL; BENZODIAZEPINE DERIVATIVE; CAPTOPRIL; CARBAMAZEPINE; DAPSONE; DILTIAZEM; GABAPENTIN; ISONIAZID; LAMOTRIGINE; MINOCYCLINE; NITROFURANTOIN; OXICAM DERIVATIVE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; SALAZOSULFAPYRIDINE; SORBINIL; SULFONAMIDE; TERBINAFINE; THALIDOMIDE; VALPROIC ACID;

ALGORITHM; ALLERGIC DISEASE; ALLERGIC REACTION; AUTOIMMUNE DISEASE; DERMATOMYOSITIS; DISEASE CLASSIFICATION; EOSINOPHILIA; GENE MUTATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; HYPEREOSINOPHILIC SYNDROME; PRIORITY JOURNAL; REVIEW; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

EOSINOPHILIA; HUMANS; MULTIPOTENT STEM CELLS; NEOPLASMS;

EID: 34249776668     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.02.010     Document Type: Review

References (121)

1. Osgood E.E., Brownlee I.E., Osgood M.W., Ellis D.M., and Cohen W. Total differential and absolute leukocyte counts and sedimentation rates. Arch Int Med 64 (1939) 105-120
2. Straumann A., and Simon H.U. The physiological and pathophysiological roles of eosinophils in the gastrointestinal tract. Allergy 59 (2004) 15-25
3. McMaster M.T., Newton R.C., Dey S.K., and Andrews G.K. Activation and distribution of inflammatory cells in the mouse uterus during the preimplantation period. J Immunol 148 (1992) 1699-1705
4. Robertson S.A., Mau V.J., Hudson S.A., and Tremellen K.P. Cytokine-leukocyte networks and the establishment of pregnancy in the mouse. J Reprod Fertil 107 (1997) 265-277
5. Gouon-Evans V., Rothenberg M.E., and Pollard J.W. Postnatal mammary gland development requires macrophages and eosinophils. Development 127 (2000) 2269-2282
6. Ehrlich P. Beiträge zur Kenntnis der granulierenden Bindegewebszellen und der eosinophilen Leukocyten. Arch Anat Physiol (1879) 166-169
7. Bain B., Pierre R., Imbert M., Vardiman J.W., Brunning R.D., and Flandrin G. Chronic eosinophilic leukaemia and the hypereosinophilic syndrome. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon 29-31
8. Ollendorff V., Guasch G., Isnardon D., Galindo R., Birnbaum D., and Pebusque M.J. Characterization of FIM-FGFR I, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation. J Biol Chem 274 (1999) 26922-26930
9. Cools J., DeAngelo D.J., Gotlib J., Stover E.H., Legare R.D., Cortes J., et al. A tyrosine kinase created by the fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348 (2003) 1201-1214
10. Gotlib J., Cross N.C.P., and Gilliland D.G. Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy. Best Pract Res Clin Haematol 3 (2006) 535-569
11. Bain B.J. Relationship between idiopathic hypereosinophilic syndrome, eosinophilic leukemia, and systemic mastocytosis. Am J Haematol 77 (2004) 82-85
12. Bain B.J. Cytogenetic and molecular genetic aspects of eosinophilic leukemias. Br J Haematol 122 (2003) 173-179
13. Spiers A.S.D., Bain B.J., and Turner J.E. The peripheral blood in chronic granulocytic leukaemia. Scand J Haematol 18 (1977) 25-38
14. Keung Y.K., Beaty M., Steward W., Jackle B., and Pettnati M. Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13) and ETV6-ABL gene rearrangement: case report and review of the literature. Cancer Genet Cytogenet 138 (2002) 139-142
15. Reiter A., Walz C., Watmore A., Schoch C., Blau I., Schlegelberger B., et al. The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCMI to Jak2. Cancer Res 65 (2005) 2662-2667
16. Simon H.U., Yousefi S., Dibbert B., Levi-Schaffer F., and Blaser K. Anti-apoptotic signals of granulocyte-macrophage colony-stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils. Eur J Immunol 27 (1997) 3536-3539
17. Steensma D.P., and Tefferi A. The myelodysplastic syndrome(s): a perspective and review highlighting current controversies. Leuk Res 27 (2003) 95-120
18. Ma S.K., Wong K.F., Chan J.K., and Kwong Y.L. Refractory cytopenia with t(1;7),+8 abnormality and dysplastic eosinophils showing intranuclear Charcot-Leyden crystals: a fluorescence in situ hybridization study. Br J Haematol 90 (1995) 216-218
19. Imai Y., Yasuhara S., Hanafusa N., Ohsaka A., Enokihara H., Tomizuka H., et al. Clonal involvement of eosinophils in therapy-related myelodysplastic syndrome with eosinophilia, translocation t(1;7) and lung cancer. Br J Haematol 95 (1996) 710-714
20. Ying S., Durham S.R., Barkans J., Masuyama K., Jacobson M., Rak S., et al. T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis. Am J Respir Cell Mol Biol 9 (1993) 356-360
21. Robinson D.S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A.M., et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326 (1992) 298-304
22. Straumann A., Bauer M., Fischer B., Blaser K., and Simon H.U. Idiopathic eosinophilic esophagitis is associated with a Th2-type allergic inflammatory response. J Allergy Clin Immunol 108 (2001) 954-961
23. Simon D., Vassina E., Yousefi S., Kozlowski E., Braathen L.R., and Simon H.U. Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment. J Allergy Clin Immunol 114 (2004) 887-895
24. Rothenberg M.E. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 113 (2004) 11-28
25. Cay A., Imamoglu M., and Cobanoglu U. Eosinophil pancreatitis mimicking pancreatic neoplasia. Can J Gastroenterol 20 (2006) 361-364
26. Hill S.M., and Milla P.J. Colitis caused by food allergy in infants. Arch Dis Child 65 (1990) 132-133
27. Bousquet J., Chanez P., Lacoste J.Y., Barnéon G., Ghavanian N., Enander I., et al. Eosinophilic inflammation in asthma. N Engl J Med 323 (1990) 1033-1039
28. Sanderson C.J. Interleukin-5, eosinophils, and disease. Blood 79 (1992) 3101-3109
29. Rothenberg M.E., and Hogan S.P. The eosinophil. Ann Rev Immunol 24 (2006) 147-174
30. Kay A.B., Phipps S., and Robinson D. A role for eosinophils in airway remodelling in asthma. Trends Immunol 25 (2004) 477-482
31. Lecki M.J., ten Brinke A., Khan J., Diamant Z., O'Connor B.J., Walls C.M., et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 356 (2000) 2144-2148
32. Kips J.C., O'Connor B.J., Langley S.J., Woodcock A., Kerstjens H.A., Postma D.S., et al. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am J Respir Crit Care Med 167 (2003) 1655-1659
33. Flood-Page P.T., Menzies-Gow A.N., Kay A.B., and Robinson D.S. Eosinophil's role remains uncertain as anti-IL-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 167 (2003) 199-204
34. Buttner C., Lun A., Splettstoesser T., Kunkel G., and Renz H. Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T cell function. Eur Respir J 21 (2003) 799-803
35. Oldhoff J.M., Darsow U., Werfel T., Katzer K., Wulf A., Laifaoui J., et al. Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis. Allergy 60 (2005) 693-696
36. Gevaert P., Lang-Loidolt D., Lackner A., Stammberger H., Staudinger H., van Zele T., et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol 118 (2006) 1133-1141
37. Stein M.L., Collins M.H., Villanueva J.M., Kushner J.P., Putnam P.E., Buckmeier B.K., et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 118 (2006) 1312-1319
38. Guillevin L., Cohen P., Gayraud M., Lhote F., Jarrousse B., and Casassus P. Churg-Strauss syndrome: clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 78 (1999) 26-37
39. Greenberger P.A. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 110 (2002) 685-692
40. Meningaud J.P., Pitak-Arnnop P., Fouret P., and Bertrand J.C. Kimura's disease of the parotid region: report of 2 cases and review of the literature. J Oral Maxillofac Surg 65 (2007) 134-140
41. Jederlinic P.J., Sicilian L., and Gaensler E.A. Chronic eosinophilic pneumonia: a report of 19 cases and a review of the literature. Medicine (Baltimore) 67 (1988) 154-162
42. Walker C., Bode E., Boer L., Hansel T.T., Blaser K., and Virchow J.C. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 146 (1992) 109-115
43. Simon H.U., Yousefi S., Schranz C., Schapowal A., Bachert C., and Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 158 (1997) 3902-3908
44. Akdis C.A., Akdis M., Simon D., Dibbert B., Weber M., Gratzl S., et al. T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J Invest Dermatol 113 (1999) 628-634
45. Cox D., Earle L., Jimenez S.A., Leiferman K.M., Gleich G.J., and Varga J. Elevated levels of eosinophil major basic protein in the sera of patients with systemic sclerosis. Arthritis Rheum 38 (1996) 939-945
46. Viallard J.F., Taupin J.L., Ranchin V., Leng B., Pellegrin J.L., and Moreau J.F. Analysis of leukemia inhibitory factor, type 1 and type 2 cytokine production in patients with eosinophilic fasciitis. J Rheumatol 28 (2001) 75-80
47. Yamazaki K., Nakadate I., Suzuki K., Sato S., and Masuda T. Eosinophilia in primary biliary cirrhosis. Am J Gastroenterol 91 (1996) 516-522
48. Nagano T., Yamamoto K., Matsumoto S., Okamoto R., Tagashira M., Ibuki N., et al. Cytokine profile in the liver of primary biliary cirrhosis. J Clin Immunol 19 (1999) 422-427
49. Heufelder A.E., Goellner J.R., Bahn R.S., Gleich G.J., and Hay I.D. Tissue eosinophilia and eosinophil degranulation in Riedel's invasive fibrous thyroiditis. J Clin Endocrinol Metab 81 (1996) 977-984
50. Kargi A., Bavbek N., Kaya A., Kosar A., and Karaaslan Y. Eosinophilia in rheumatologic diseases: a prospective study of 100 cases. Rheumatol Int 24 (2004) 321-324
51. Wakugawa M., Nakamura K., Hino H., Toyama K., Hattori N., Okochi H., et al. Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia. Br J Dermatol 143 (2000) 112-116
52. Eriksson M.O., Hagforsen E., Lundin I.P., and Michaelsson G. Palmoplantar pustulosis: a clinical and immunohistological study. Br J Dermatol 138 (1998) 390-398
53. Rasi A., and Khatami A. Autoimmune progesterone dermatitis. Int J Dermatol 43 (2004) 588-590
54. Klion A.D., and Nutman T.B. The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol 113 (2004) 30-37
55. Sturrock R.F., Kimani R., Cottrell B.J., Butterworth A.E., Seitz H.M., Siongok T.K., et al. Observations on possible immunity to reinfection among Kenyan schoolchildren after treatment for Schistosoma mansoni. Trans R Soc Trop Med Hyg 77 (1983) 363-371
56. Coffman R.L., Seymour B.W., Hudak S., Jackson J., and Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245 (1989) 308-310
57. MacDonald S.M., Bhisutthibhan J., Shapiro T.A., Rogerson S.J., Taylor T.E., Tembo M., et al. Immune mimicry in malaria: Plasmodium falciparum secretes a functional histamine-releasing factor homolog in vitro and in vivo. Proc Natl Acad Sci U S A 98 (2001) 10829-10832
58. Ansarin H., Jalali M.H., Mazloomi S., Soltani-Arabshahi R., and Setarehshenas R. Scabies presenting with bullous pemphigoid-like lesions. Dermatol Online J 12 (2006) 19
59. Wood C., Miller A.C., Jacobs A., Hart R., and Nickoloff B.J. Eosinophilic infiltration with flame figures: a distinctive tissue reaction seen in Wells' syndrome and other diseases. Am J Dermatopathol 8 (1986) 186-193
60. Lehrer R.I., Szklarek D., Barton A., Ganz T., Hamann K.J., and Gleich G.J. Anti-bacterial properties of eosinophil major basic protein (MBP) and eosinophil cationic protein (ECP). J Immunol 142 (1989) 4428-4434
61. Plötz S.G., Lentschat A., Behrendt H., Plötz W., Hamann L., Ring J., et al. The interaction of human peripheral blood eosinophils with bacterial lipopolysaccharide is CD14 dependent. Blood 97 (2001) 235-241
62. Zhang N., Gevaert P., van Zele T., Perez-Novo C., Patou J., Holtappels G., et al. An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis. Rhinology 43 (2005) 162-168
63. Cardona I.D., Cho S.H., and Leung D.Y. Role of bacterial superantigens in atopic dermatitis: implications for future therapeutic strategies. Am J Clin Dermatol 7 (2006) 273-279
64. Yousem S.A. Graft eosinophilia in lung transplantation. Hum Pathol 23 (1992) 1172-1177
65. Berger B.W., Clemmensen O.J., and Ackerman A.B. Lyme disease is a spirochetosis: a review of the disease and evidence for its cause. Am J Dermatopathol 5 (1983) 111-124
66. Granter S.R., Barnhill R.L., Hewins M.E., and Duray P.H. Identification of Borrelia burgdorferi in diffuse fasciitis with peripheral eosinophilia: borrelial fasciitis. JAMA 272 (1994) 1283-1285
67. Papi A., Luppi F., Franco F., and Fabbri L.M. Pathophysiology of exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 3 (2006) 245-251
68. Coyle A.J., Erard F., Bertrand C., Walti S., Pircher H., and Le Gros G. Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia. J Exp Med 181 (1995) 1229-1233
69. Busse W.W., and Gern J.E. Viruses in asthma. J Allergy Clin Immunol 100 (1997) 147-150
70. Becker Y. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy: a review. Virus Genes 33 (2006) 235-252
71. Slifman N.R., Loegering D.A., McKean D.J., and Gleich G.J. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J Immunol 137 (1986) 2913-2917
72. Clerici M., and Shearer G.M. A Th1->Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 14 (1993) 107-111
73. Whittaker S.J., Ng Y.L., Rustin M., Levene G., McGibbon D.H., and Smith N.P. HTLV-1-associated cutaneous disease: a clinicopathological and molecular study of patients from U.K. Br J Dermatol 128 (1993) 483-492
74. Sasama J., Sherris D.A., Shin S.H., Kephart G.M., Kern E.B., and Ponikau J.U. New paradigm for the roles of fungi and eosinophils in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 13 (2005) 2-8
75. Shin S.H., Ponikau J.U., Sherris D.A., Congdon D., Frigas E., Homburger H.A., et al. Rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 114 (2004) 1369-1375
76. Fischer Casagrande B., Flückiger S., Tengvall Linder M., Johansson C., Scheynius A., Crameri R., et al. Sensitization to the yeast Malassezia sympodialis is specific for extrinsic and intrinsic atopic eczema. J Invest Dermatol 126 (2006) 2414-2421
77. Schaffer J.V. The changing face of graft-versus-host disease. Semin Cutan Med Surg 25 (2006) 190-200
78. Janin A., Socie G., Devergia A., Aractingi S., Esperou H., Verola O., et al. Fasciitis in chronic graft-versus-host disease: a clinicopathologic study of 14 cases. Ann Intern Med 120 (1994) 993-998
79. Jacobsohn D.A., Schechter T., Seshadri R., Thormann K., Duerst R., and Kletzel M. Eosinophilia correlates with the presence or development of chronic graft-versus-host disease in children. Transplantation 77 (2004) 1096-1100
80. Basara N., Kiehl M.G., and Fauser A.A. Eosinophilia indicates the evolution to acute graft-versus-host disease. Blood 100 (2002) 3055
81. Aleman K., Noordzij J.G., de Groot R., van Dongen J.J.M., and Hartwig N.G. Reviewing Omenn syndrome. Eur J Pediatr 160 (2001) 718-725
82. Grimbacher B., Holland S.M., Gallin J.I., Greenberg F., Hill S.C., Malech H.L., et al. Hyper-IgE syndrome with recurrent infections: an autosomal dominant multisystem disorder. N Engl J Med 340 (1999) 692-702
83. Simon H.U., and Seger R. Hyper-IgE syndrome associated with an IL-4-producing γ/δ+ T-cell clone. J Allergy Clin Immunol 119 (2007) 246-248
84. Jaggi P., Freeman A.F., and Katz B.Z. Chronic granulomatous disease presenting with eosinophilic inflammation. Pediatr Infect Dis J 24 (2005) 1020-1021
85. Jezior D., Boratynska M., Halon A., Kusztal M., Rabczynski J., Szyber P., et al. Biopsy eosinophilia as a predictor of renal graft dysfunction. Transplant Proc 35 (2003) 2182-2185
86. Meleg-Smith S., and Gauthier P.M. Abundance of interstitial eosinophils in renal allografts is associated with vascular rejection. Transplantation 79 (2005) 444-450
87. Wolff D., Steiner B., Stilgenbauer S., Kahl C., Leithauser M., Junghanss C., et al. Treatment with campath-1H for relapsed chronic lymphocytic leukemia after allogeneic peripheral blood stem cell transplantation does not abrogate the development of chronic GVHD. Eur J Haematol 72 (2004) 145-148
88. Simon H.U., Plötz S.G., Dummer R., and Blaser K. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 341 (1999) 1112-1120
89. Cogan E., Schandené L., Crusiaux A., Cochaux P., Velu T., and Goldman M. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 330 (1994) 535-538
90. Simon H.U., Yousefi S., Dommann-Scherrer C.C., Zimmermann D.R., Bauer S., Barandun J., et al. Expansion of cytokine-producing CD4-CD8-T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med 183 (1996) 1071-1082
91. Simon H.U., Plötz S.G., Simon D., Dummer R., and Blaser K. Clinical and immunological features of patients with interleukin-5-producing T cell clones and eosinophilia. Int Arch Allergy Immunol 124 (2001) 242-245
92. Klion A.D., Bochner B.S., Gleich G.J., Nutman T.B., Rothenberg M.E., Simon H.U., et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol 117 (2006) 1292-1302
93. Roujeau J.C. Clinical heterogeneity of drug hypersensitivity. Toxicology 209 (2005) 123-129
94. Wolf R., Matz H., Marcos B., and Orion E. Drug rush with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification. Clin Dermatol 23 (2005) 311-314
95. Pichler W.J. Pharmacological interaction of drugs with antigen-specific immune responses: the p-i concept. Curr Opin Allergy Clin Immunol 2 (2002) 301-305
96. Pichler W.J. Direct T-cell stimulations by drugs: bypassing the innate immune system. Toxicology 209 (2005) 95-100
97. Dicker R.M., James N., and Cunha B.A. The eosinophilia-myalgia syndrome with neuritis associated with L-tryptophan use. Ann Intern Med 112 (1990) 957-958
98. Rigau-Perez J.G., Perez-Alvarez L., Duenas-Castro S., Choi K., Thacker S.B., Germain J.L., et al. Epidemiologic investigation of an oil-associated pneumonic paralytic eosinophilic syndrome in Spain. Am J Epidemiol 119 (1984) 250-260
99. Owen W.F., Petersen J., Sheff D.M., Folkerth R.D., Anderson R.J., Corson J.M., et al. Hypodense eosinophils and interleukin-5 activity in the blood of patients with eosinophilia-myalgia syndrome. Proc Natl Acad Sci U S A 87 (1990) 8647-8651
100. Nagai Y., Mori T., Abe T., and Nomura G. Immediate-type allergy against human insulin associated with marked eosinophilia in type 2 diabetic patient. Endocr J 48 (2001) 311-316
101. Silberstein D.S., Schoof D.D., Rodrick M.L., Tai P.C., Spry C.J., Davis J.R., et al. Activation of eosinophils in cancer patients treated with interleukin-2 and interleukin-2-generated LAK cells. J Immunol 142 (1989) 2162-2167
102. Groopman J.E., Mitsuyasu R.T., DeLeo M.J., Oette D.H., and Golde D.W. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med 317 (1987) 593-599
103. Chan J.L., Davis-Reed L., and Kimball A.B. Counter regulatory balance: atopic dermatitis in patients undergoing infliximab infusion therapy. J Drugs Dermatol 3 (2004) 315-318
104. Bonnekoh B., Schulz M., Franke I., and Gollnick H. Complete remission of a primary cutaneous B-cell lymphoma of the lower leg by first-line monotherapy with the anti-CD20-antibody rituximab. J Cancer Res Clin Oncol 128 (2002) 161-166
105. Plötz S.G., Simon H.U., Darsow U., Simon D., Vassina E., Yousefi S., et al. Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. N Engl J Med 349 (2003) 2334-2339
106. Butterfield J.H., Leiferman K.M., Abrams J., Silver J.E., Bower J., Gonchoroff N., et al. Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood 79 (1992) 688-692
107. Rioux J.D., Stone V.A., Daly M.J., Cargill M., Green T., Nguyen H., et al. Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5Q31-q33. Am J Hum Genet 63 (1998) 1086-1094
108. Gruss H.J., Herrmann F., and Drexler H.G. Hodgkin's disease: a cytokine- producing tumor: a review. Crit Rev Oncogenesis 5 (1994) 473-538
109. Ionescu M.A., Rivet J., Daneshpouy M., Briere J., Morel P., and Janin A. In situ eosinophil activation in 26 primary cutaneous T-cell lymphomas with blood eosinophilia. J Am Acad Dermatol 52 (2005) 32-39
110. Borish L., Dishuck J., Cox L., Mascali J.J., Williams J., and Rosenwasser L.J. Sezary syndrome with elevated IgE and hypereosinophilia: role of dysregulated cytokine production. J Allergy Clin Immunol 92 (1993) 123-131
111. Tono-oka T., Sato Y., Matsumoto T., Ueno N., Ohkawa M., Shikano T., et al. Hypereosinophilic syndrome in acute lymphoblastic leukemia with a chromosomal translocation [t(5q;14q)]. Med Pediatr Oncol 12 (1984) 33-37
112. Hogan T.F., Koss W., Murgo A.J., Amato R.S., Fontana J.A., and VanScoy F.L. Acute lymphoblastic leukemia with chromosomal 5:14 translocation and hypereosinophilia: case report and literature review. J Clin Oncol 5 (1987) 382-390
113. Meeker T.C., Hardy D., Willman C., Hogan T., and Abrams J. Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia. Blood 76 (1990) 285-289
114. Laman J.D., Leenen P.J.M., Annels N.E., and Hogendoorn P.C.W. Egeler RM. Langerhans-cell histiocytosis "insight into DC biology.". Trends Immunol 24 (2003) 190-196
115. Lowe D., Jorizzo J., and Hutt M.S.R. Tumour-associated eosinophilia: a review. J Clin Pathol 34 (1981) 1343-1348
116. Geisinger K.R., Steffee C.H., McGee R.S., Woodruff R.D., and Buss D.H. The cytomorphologic features of sclerosing mucoepidermoid carcinoma of the thyroid gland with eosinophilia. Am J Clin Pathol 109 (1998) 294-301
117. Horie S., Okubo Y., Suzuki J., and Isobe M. An emaciated man with eosinophilic pneumonia. Lancet 348 (1996) 166
118. Fridlender Z.G., Simon H.U., and Shalit M. Metastatic carcinoma presenting with concomitant eosinophilia and thromboembolism. Am J Med Sci 326 (2003) 98-101
119. Dibbert B., Daigle I., Braun D., Schranz C., Weber M., Blaser K., et al. Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocyte- macrophage colony-stimulating factor and interleukin-5. Blood 92 (1998) 778-783
120. Vassina E.M., Yousefi S., Simon D., Zwicky C., Conus S., and Simon H.U. cIAP-2 and survivin contribute to cytokine-mediated delayed eosinophil apoptosis. Eur J Immunol 36 (2006) 1975-1984
121. Rothenberg M.E. Eosinophilia. N Engl J Med 338 (1998) 1592-1600